Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
How likely is it that they will be producing product in India by the end of 2019? Thoughts?
Patriot One Update Call with CEO Martin Cronin
By Daniel Carlson - January 17, 2019 Tailwinds Research
I managed to catch up on the phone with Martin Cronin today. Which was good as I had many urgent issues to discuss with him. I mean, it had been well over a month since we last spoke and during that time much had happened.
Think about it for a minute. During the last couple weeks I had learned quite a lot about the Company that had never been revealed before. I needed answers to these new questions. For example, I’ve been hearing that PATSCAN has been removed from Westgate. I’ve been told that the antenna design has failed. And, I’ve even learned that the whole Company is a scam. Bottom line: things were disintegrating rapidly at Patriot One and I needed answers!
Thankfully, Martin talked me down from the edge. It turns out that (possibly) over-zealous shareholders are behind these rumors. Westgate is definitively not pulling the system, the antenna actually works just fine, and the Company is legit. Phew!!!
Having settled the fake news, Martin and I proceeded to have a nice update call. Most of what we discussed was covered in last week’s NFORCED newsletter. If you haven’t read it, I suggest you do so; here’s the link.
The Company continues to make headway in getting their product to market. Pre-paid pilots are being installed in multiple locations during this quarter. These installations are combinations of both the CMR and VRS, which means they have integrated the EhEye acquisition very rapidly.
Thus, the Company remains on track for a second quarter rollout of their product. Martin was quick to make sure I understood that the rollout was only happening in regions where it is approved, such as the U.S. So, until all jurisdictions have regulatory approval, it’s not a complete global rollout. To which I say, Who Cares? It’s happening in Q2, baby!
I, for one, am excited to see the rollout finally happening. It’s been years in the making, kudos to the patient investors who stuck around.
Kudos also for all their hard work to the management and founders of Patriot One. Make no mistake, this has been a long slog for them. Probably a lot longer than anyone ever thought it would be.
In many ways, running this Company in particular has got to be one of the toughest CEO jobs ever. I’m 100% convinced I wouldn’t want the role. Yet, Martin has done a fabulous job. Sure, it’s taken longer than expected. It has also gotten much bigger than originally planned.
When I first got involved with PAT, it was a one trick pony. The CMR was all that existed and getting it to market was the sole priority. Admittedly, as with every novel technology, there were unseen challenges that cropped up along the road.
Simultaneously, the road changed direction. Instead of just selling the CMR, Patriot One is turning into a security platform. They are integrating multiple products and testing others that will likely be added to the mix. Think that will slow things down?
Investors seem to be all over the Company for delays, dilution, etc. Martin’s words are pored over and outrage seems to be the word of the day in chat rooms. It’s his job to manage this…while also managing partnerships like Cisco and IBM. Think about that for a second. Martin goes from negotiating a deal with Cisco, installing PATSCAN in IBM’s Montreal innovation center, to worrying about how best to handle rumors of his Company’s failures. Ugh.
For my investors, the people whose money I manage, I am clear; this space is Public Venture Capital. The companies are early stage. They have great ideas, but a lot of execution lies in front of them before achieving success.
I also say that the key to investing in this field is backing the right management teams. The people who can build an organization, take a product from napkin to installations, and sit down at the table with the big boys and belong there.
I’m very pleased with the team at Patriot One and the progress they have made. Could it have been done quicker? I am not sure. But, quickness is not the most important thing. When your end market is security, you can’t afford to go to market before you’re ready. Therefore, having a rational, methodical process of development and real world rollout is much more important than haste to market. PAT has done this for sure.
The highlight of my call was nothing Martin said, but how he said everything. He is clear, rational, and poised. More importantly, he is very confident and this comes through. Patriot One is on the cusp of changing building and perimeter security in the world. They have strong partners and are going to market in a few short weeks. Martin is highly confident this is coming together…and so am I.
So, in other words, they are still working on it, and at this point, don't have a product ready to go?
Is there comparison information available for quantum dots vs silicon:
Efficiency
Price
When should revenue start?
Thanks!
INVO Bioscience Closes Exclusive U.S. Licensing Agreement with Ferring Pharmaceuticals to Commercialize the Novel INVOcell™ System
$5.0 million up front plus $3.0 million in additional milestone payments
? Receive payment for the supply of each INVOcell device.
? Defined minimum revenue targets over the next seven (7) years.
I didn't see the range of their device. Is it greater than 2 meters?
Thanks!
Is this a big deal?
Tech Dinosaurs Surge (Prediction)
"$CSCO nearly 20 years in the making, but 2019 this will finally return to its dot com glory days and lead the tech segment higher. " - @Gpaisa
TORONTO, December 20, 2018 –– Patriot One Technologies Inc. (TSX.V: PAT) (OTCQX: PTOTF) (FRANKFURT: 0PL) (“Patriot One” or the “Company”), developer of the award-winning PATSCAN™ covert weapon detection system, is pleased to advise that Q4 2018 saw significant advancements in the PATSCAN CMR and VRS threat detection solutions development, including moving to rollouts of paid trials with its global security integrator/reseller network which represents a potential client-base of thousands of schools and universities, resorts, casinos, retail and government facilities.
“Two weeks ago, I was pleased to announce our first paid trial programs with several partners including Florida-based Smart CT Solutions, and the Government of Canada’s Department of National Defence as part of the federal ‘Build in Canada Innovation Program’,” said Martin Cronin, CEO and President of Patriot One Technologies. “Today, I am excited to inform that we will now begin shipping PATSCAN products to several other global security integrators to support paid product trials in their respective markets.”
Global Paid Trials Begin Q4, 2018:
At the request of our security integrators, the Company has embraced a “paid trial” model enabling Patriot One to scale efficiently and cost-effectively through its reseller network. This effort meets Phase 4 of its previously described Lab-to-Market strategy.
Paid trials aim to ultimately transition into commercial deployment, effectively launching product rollout. The Company will finalize policies, procedures, terms and PATSCAN installation training with its resellers in preparation for ongoing commercial activity in Q2, 2019.
No other company has ever mass-deployed these types of integrated threat detection technologies before. Therefore, advancement into full-scale mass production is, by necessity, constrained until completion and review of the technical trial results.
Three (3) Business Goals Achieved
revenues as planned commencing Q4 2018
successful deployments of PATSCAN products with key security system integrators and their clients during Q4 2018, and
advanced live tests and trials of PATSCAN solutions with a broad end-user base, targeting transition from paid trials to commercial deployments.
Related Quarterly Announcements
Additional Funding Closed: Mid-November brought the close of a $46M CAD bought deal from Canaccord Genuity and GMP. The proceeds will help drive evaluation and assembly of an extended PATSCAN product lineup of covert solutions.
EhEye Acquisition: Completed the strategic acquisition of EhEye, Inc. video analytics and object recognition technology. Re-branded as PATSCAN VRS, this innovative threat detection solution has begun paid trial deployment with Patriot One’s reseller network.
University of North Dakota: As implementation of the University Of North Dakota’s Centre of Excellence in Threat Detection accelerates forward, UND has invested USD$100,000 for trial deployment of PATSCAN systems in four separate facilities across campus.
Innovation Programs: Through Cisco Systems Innovation Program, Patriot One joined Cisco’s sales team in presenting PATSCAN solutions to key clients. The Company launched PATSCAN showcases within Cisco’s Toronto-based and IBM’s Montreal-based Innovation Centre’s.
Public Policy efforts: Ongoing representation in Washington DC to advise and inform key decision makers regarding product rollout. Met with members of Congress, the Department of Homeland Security, Secret Service and Pentagon officials. Company executives also met with the ACLU to discuss PATSCAN deployment in a civil liberties and privacy context.
Defence Contractor Partnership: Our partner, a major international defence contractor, is anticipating government approval in the coming weeks, at which time a detailed announcement will be made.
Media & Public Relations Coverage: Mainstream media includes ABC, CBS and NBC featured coverage of PATSCAN demonstrations at the Company’s Las Vegas Development Centre. The Company further earned media coverage with key European and UK publications including INTERSEC-Journal of International Security, Defence Online, Defence Contracts Magazine and MOD Defence Contracts Bulletin.
We look forward to a great year ahead working to build safer communities and to deliver shareholder value. We thank our many partners and supporters for their continued confidence.
On Behalf of the Board,
“Martin Cronin”
Martin Cronin, President, CEO & Director
Will CBD prices be coming down now?
President Donald J. Trump holds a roundtable discussion on school safety at the White House | December 18, 2018
Peterson: Farm Bill Could Be Passed Next Week
https://agview.net/articles/features/2018-12-06-peterson-farm-bill-could-be-passed-next-week
The Ranking Democrat of the House Agriculture Committee predicts the farm bill will be considered next week. Representative Collin Peterson of Minnesota told reporters this week the bill is nearly finalized and should be filed Monday, with House consideration Wednesday and Senate consideration Thursday.
Peterson says the bill would rename the Margin Protection Program and change the way it operates in an effort to better help dairy farmers. He says dairy farmers “got the best deal” out of the agreement, and “they needed it.” The bill includes another provision that will refund half the premiums paid under the MPP program “because everybody thought they got ripped off.” Peterson also says of the agreement in principle that it would raise the Conservation Reserve Program, or CRP, acreage by three million acres, but reform how it works.
He says there are also changes in how yield is calculated in the Ag Risk Coverage and Price Loss Coverage programs. Full details of the bill will be made available next week.
Where?
Thanks!
When was the last time George spoke to us?
"Particular progress has been made on CMR-1 hardware configuration (i.e., with the Company’s 6th generation antenna) which has resulted in an advancement in performance and has allowed the Company to look to early stage pilot deployments of the CMR-1. Also, the Company is in the final stages of documentation for submission for relevant government approval with respect to its agreement in principle with the international defence contractor (see “Recent Developments”). If approved, this will be a significant milestone in unlocking a substantial multi-year co-funded innovation pipeline"
Company to receive $8mil+ from Ferring
From 10Q:
"Under the terms of the Distribution Agreement, Ferring is obligated to make an initial payment to the Company of $5,000,000 upon satisfaction of certain closing conditions, including an agreement from all current manufacturers of the Licensed Product that upon a material supply default by the Company, Ferring can assume a direct purchase relationship with such manufacturers. The Closing under the Distribution Agreement will not occur prior to January 14, 2019 without consent of the Company and Ferring. Ferring is obligated to make a second payment to the Company of $3,000,000 provided that the Company is successful in obtaining a five (5) day label enhancement from the FDA for the current incubation period for the Licensed Product at least three (3) years prior to the expiration of the term of the license for the Licensed Product and provided further that Ferring has not previously exercised its right to terminate the Distribution Agreement for convenience. In addition, under the terms of a separate Supply Agreement, attached as an exhibit to the Distribution Agreement, Ferring is obligated to pay the Company a specified supply price for each Licensed Product purchased by Ferring for distribution.
The Distribution Agreement has an initial term expiring on December 31, 2025 and at the end of the initial term it may be terminated by the Company if Ferring fails to generate specified minimum revenues to the Company from the sale of the Licensed Product during the final two years of the initial term. Provided that no such termination occurs at the end of the initial term, thereafter the term of the Distribution Agreement shall automatically be renewed for successive three (3) years terms unless terminated by mutual consent. The Distribution Agreement is subject to termination upon a material breach by either party, or by Ferring for convenience. In addition, if the closing under the Distribution Agreement does not occur within seventy five (75) days, a non-breaching party may elect to terminate the Distribution Agreement."
MEDFORD, Mass., Nov. 13, 2018 /PRNewswire/ -- INVO Bioscience, Inc. (IVOB), developers of the INVOcell intravaginal culture (IVC) system, and Ferring Pharmaceuticals, a specialty biopharmaceutical group committed to helping people around the world build families and live better lives, announced today that the companies have entered into an exclusive U.S. commercialization rights agreement for INVOcell. Ferring will be responsible for all U.S. commercial activities for INVOcell. INVO Bioscience will be responsible for manufacturing and supplying INVOcell to Ferring for commercial sales and to obtain a five (5) day label enhancement from the FDA for the current incubation period for the product. INVO Bioscience also retains certain limited rights to establish INVO clinics that exclusively commercialize INVO cycles and will retain commercialization rights outside the U.S.
INVO Bioscience (IVOB) is a medical device company, headquartered in Medford, Massachusetts, focused on creating simplified, lower cost treatment options for patients diagnosed with infertility. The company's lead product, the INVOcell, is a novel medical device used in infertility treatment that enables egg fertilization and early embryo development in the woman's vaginal cavity.
INVO Bioscience (IVOB) is a medical device company, headquartered in Medford, Massachusetts, focused on creating simplified, lower cost treatment options for patients diagnosed with infertility. The company's lead product, the INVOcell, is a novel medical device used in infertility treatment that enables egg fertilization and early embryo development in the woman's vaginal cavity.
More
The agreement is expected to close in January 2019, subject to customary closing conditions.
"We are pleased to have reached this agreement with Ferring to commercialize INVOcell in the U.S.," said Katie Karloff, Chief Executive Officer of INVO Bioscience. "Ferring has commercial strength and market presence within the pharmaceutical fertility market and understands the unique opportunity that INVOcell provides to revolutionize fertility treatment. Our joint mission at INVO Bioscience and Ferring is to increase access to care and expand fertility treatment across the U.S., and with Ferring we've found a natural partner to accomplish this goal."
"As a leader in reproductive medicine, Ferring understands that women seeking to start or expand a family want options that suit their individual circumstances," said Paul Navarre, CEO, Ferring Pharmaceuticals (US). "With this agreement, Ferring aims to make INVOcell, a novel technology used in the treatment of infertility, widely available as an option for women and their healthcare providers."
INVOcell is a novel fertility treatment that uses a woman's own body as a natural incubator for the incubation of eggs and sperm during fertilization and early embryo development. In 2015, INVOcell received US Food & Drug Administration clearance. INVOcell is the first intravaginal culture (IVC) device and is a small polystyrene capsule used for egg fertilization and embryo development using vaginal incubation. In clinical studies supporting the FDA clearance, INVOcell has shown results comparable to traditional assisted reproductive techniques.
"In my practice, an increasing number of women and couples are choosing INVOcell with favorable results," said Amber R. Cooper MD, MSCI, FACOG, Medical and IVF Practice Director of Vios Fertility Institute St. Louis, MO. "There is a growing consensus around the need for personalized medicine in reproductive health. That Ferring and INVO Bioscience are moving to make INVOcell an available option for infertility patients across the country is very welcome news."
In the United States, statistics show that over 1.4 million women may benefit from advanced fertility treatment. However, only approximately 130,000 people begin such treatment.i
Additional details pertaining to the agreement will be filed by INVO Bioscience with the SEC.
About INVO Bioscience
INVO Bioscience is a medical device company focused on creating simplified treatments for patients diagnosed with infertility. Our solution, the INVO Procedure, is a disruptive new technology. The INVO Procedure is a revolutionary in vivo method of vaginal incubation that offers patients a more natural and intimate experience. Our lead product, the INVOcell, is a patented medical device used in infertility treatment and is considered an Assisted Reproductive Technology (ART). The INVOcell is the first Intravaginal Culture (IVC) system in the world used for the natural in vivo incubation of eggs and sperm during fertilization and early embryo development. Our mission is to increase access to care and expand fertility treatment across the globe with a goal to lower the cost of care and increase availability of care. For more information, please visit https://invobioscience.com.
For Safety and Efficacy information:
https://invobioscience.com/wp-content/uploads/2018/11/P-008_INVO-IFU-Nov-2018.pdf
Safe Harbor Statement
This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The Company invokes the protections of the Private Securities Litigation Reform Act of 1995. All statements regarding our expected future financial position, results of operations, cash flows, financing plans, business strategies, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, as well as statements that include words such as "anticipate," "if," "believe," "plan," "estimate," "expect," "intend," "may," "could," "should," "will," and other similar expressions are forward-looking statements. All forward-looking statements involve risks, uncertainties and contingencies, many of which are beyond our control, which may cause actual results, performance, or achievements to differ materially from anticipated results, performance, or achievements. Factors that may cause actual results to differ materially from those in the forward- looking statements include those set forth in our filings at www.sec.gov. We are under no obligation to (and expressly disclaim any such obligation to) update or alter our forward-looking statements, whether as a result of new information, future events or otherwise.
For more information, please contact
Kathleen Karloff, CEO
978-878-9505 ext. 504
kkarloff@invobio.com
i Fertility Dynamics, an independent data analytics, research and strategic advisory firm based in Washington, DC; data on file
I think they have a substantial infrastructure in place now; so I can see 450 units installed!
https://seekingalpha.com/article/4219887-patriot-one-security-future?dr=1
Summary
Patscan CMR, the revolutionary, covert, cognitive microwave technology designed to detect all weapons, has over 90% accuracy rate with AI/ML to continue improving detection rate.
Pre-revenue (backlog over $4 million) with sales launching in coming months as it has taken out a $40 million bought deal after partnering with Cisco under its Innovation Program.
Patriot One management and background includes affiliation with DARPA on initial sponsorship, technology utilization in Iraq and Afghanistan, and it has added Tom Ridge (first DHS Secretary) to their advisory board.
Patriot One board members have met with officials from the White House and Congress in recent months and Canadian police, military, and governmental officials in November, in addition to having a backlog in sales to Pretoria, South Africa.
Though there is strong upside, risks include: the company is pre-revenue, its product may not become adopted, government funding may go elsewhere, and larger companies may develop their own proprietary products.
Editor's note: Seeking Alpha is proud to welcome Matthew McConnell as a new contributor. It's easy to become a Seeking Alpha contributor and earn money for your best investment ideas. Active contributors also get free access to the SA PRO archive. Click here to find out more »
Patriot One Technologies (OTCQX:PTOTF) specializes in an untapped, underdeveloped market in public security. In 2017 the public security market was an astonishing $277 billion and is projected to double to an astounding $532 billion global market within the next four years (CAGR ~15%, but other research projects upwards of a 35% CAGR for certain niche public security markets). The exact market Patriot One is in, the transportation system vertical, is the most promising one with the highest projected CAGR and most avenues for funding. Already a company with a presence in schools ranging from Florida to North Dakota, and hotels in Las Vegas, Patriot One seeks to expand not only within the public market through government contracts, but also the private market in hotels and other businesses. With the amount of different avenues for sales, the upside potential is stark.
There are over 100,000 schools in the nation and an estimated 3 million schools in the world. There are over 500,000 hotels, and over 100 million businesses (STR Global). Notwithstanding the numbers in the CAGR and estimated size in the public security business, the rise of nationalistic tendencies, rising domestic and international terrorism, and the intrinsic fear instilled in those witnessing the heinous events occurring more often around the world cannot be underestimated. There are currently no products marketed that are able to detect as accurately with innovative proprietary technology as Patriot One's Patscan and other pending products promise to do. As a supplement to metal detectors and security guards, or to cost-cut or promote cost-efficiency in the market, or to provide the first form of security in any soft-spot building without security features, the $10,000 cost of the Patscan may be the most effective form of covertly identifying any weapon, anywhere. This is all while TSA bodyscanners and metal detectors cost a whopping $150,000 and $30,000, respectively. From 2008 onwards, the government paid over $160 million on airport security for these products alone. According to Politico,
Senate Homeland Security Chairman Ron Johnson has such low confidence in the scanners’ ability to catch explosives and weapons that he says the agency should make fliers walk through metal detectors after passing through the body imaging machines.
There had been other security devices sponsored by the federal government that too woefully failed. This raises the question: why spend $150,000 for a bodyscanner, or $180,000 for both that and a metal detector, rather than cut costs by over 90% for a covert, more accurate detection system?
If Patriot One were to have received this contract alone, for about 1,000 American airports, they would have made $10 million in revenue in initial sales (not taking into account recurring software as a service revenue). That too, is solely based off of one product: the Patscan CMR. South Carolina Representative Gillard has also proposed a bill to mandate security metal detectors at the entrance of every school in his state, costing $14.4 million up front (lower-end detectors cost only a few thousand dollars and may be circumvented easily or through other points of entry). Such a deal for Patriot One would see revenue likely three times that for the state alone. The backlog Patriot One does have in sales is represented through 4,000 units pre-ordered, or $4 million. The current valuation of over 50x expected sales is lofty right now, but it is important to note that the product has yet to launch, and pre-order numbers have not been updated in months. If Patriot One may penetrate 10% of airports and 10% of schools in the nation, revenue from those two avenues alone would amount to over $100 million in sales. Keep in mind that Patriot One is launching globally, with prospective sales to regions ranging from South Africa to Europe.
Having a product more versatile, more discreet, and more innovative than traditional metal detectors, which have many of their own flaws to begin with (compliance to go through, walking around, only detecting metal), the Patscan may detect any weapon by analyzing the shape rather than solely the composition. Pressure plates, knives, any firearm, can be detected with supreme accuracy. In situations where an active threat may be on the outside, or if the threat bypassed a certain Patscan entryway, the next additions to the Patriot One product pipeline include interior and exterior (parking lots, outdoor venues) scanners that traditional security equipment have no way in detecting.
The Patscan $10,000 initial price (70% gross margin) is the first stride in branding both a leader in global security and a profitable company. The other products launching in 2019 do not have a current price tag, yet would likely price at a similar gross margin. CEO Martin Cronin is seeking to add a recurring revenue source as well by means of using the software as a service by encompassing the several units into one online platform that may connect to cloud services within the building, to high-speed internet cables, and thus to local police as well. This is why the partnership with Cisco (CSCO) is so essential for Patriot One. In addition to the possibility of a buyout by Cisco, which happens quite often in the Cisco Innovation pipeline, the connection between Patriot One's products and Cisco's network may only enhance the scalability, the efficiency, the brand-name, and the rollout with possible additional funding.
Funding seems to be another way for Patriot One to insulate itself from the high operating costs and cost of revenue that many rising technology stars have. As a disruptive technology comparison, Square (SQ), Roku (ROKU), and Netflix (NFLX), with market values between $6 billion and over $130 billion, are the classic tech plays that are prone to cash burn and an unfriendly junk bond market that only increases interest payments on continuing operations in the income statement. Patriot One, on the other hand, has the ability to tap revolvers and middle market lending (yet at high rates as well), but a more strategic move is one they have already been pursuing. Having met with Congress twice this year, as well as with White House representatives, Canadian officials, and the South African government (pre-sales in Pretoria), Patriot One may have the means to cover costs through government funding. The US, as of March 23, 2018, has provided an omnibus spending bill to school security through the Consolidated Appropriations Act to allot a $1 billion matching grant programs through the Department of Justice. Between 2008 and 2015, the Law Enforcement Terrorism Prevention Activity (LETPA) Funding hit $10 billion in conjunction with the following purposes, among others:
(A) information sharing and analysis;
(B) target hardening;
(C) threat recognition;
(D) terrorist interdiction;
(E) training exercises to enhance preparedness for and response to mass casualty and active shooter incidents and security events at public locations, including airports and mass transit systems;
(F) overtime expenses consistent with a State homeland security plan, including for the provision of enhanced law enforcement operations in support of Federal agencies, including for increased border security and border crossing enforcement;...
Once again, in an infantile market without much competition, just look to Shotspotter (SSTI). A few partnerships on "Smart Cities" and about $30 million in revenue, they had quadrupled YTD until the recent selloff. Trading at 15x sales and over 200x forward PE, the company launched an innovative product in an untapped public security industry. As Patriot One is proactive, rather than reactive like Shotspotter, there is no reason Patriot One and its capable board and products should perform any worse than their industry peer.
Moving forward, getting a small position below $2 a share could be a good first move before adding more exposure. The company has yet to launch their product, naturally adding a degree of risk in the timetable for the rest of their products. Though there are also possible competitors with billions of dollars in cash on their balance sheets, such as IBM (IBM) or Northrop Grumman (NOC), there has yet to be a product launched with the same covert design, the AI/ML that refines the technology, and the covert nature of the machine. There is no certainty that companies, public facilities, and venues will adopt this technology on a broad scale. There are security measures in many places already, as rudimentary and costly as they may be. However, having patents, international exposure, a well-connected board, and a major partnership with Cisco, Patriot One is situated well for a pre-revenue company. With a prospective launch in the coming months, a small position can be augmented with higher conviction trades as the security roles out. However, being early to a promising company may have greater upside potential than downside, especially with its established credibility.
Disclosure: I am/we are long PTOTF.
I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Editor's Note: This article covers one or more microcap stocks. Please be aware of the risks associated with these stocks.
Is "Trader Moni" facilitated through EMailMoni?
Bounced off of support at .02; coming back up!
"The Company is also expecting to receive the label approval for its first hemp beer, Major Hemp Brown Ale (MHBA) and begin production with its Colorado contract brewer, Sleeping Giant, soon. MHBA will also be available in kegs and cans."
I thought we already had this approval?
Candlesticks warned us today to be on alert with a new bearish pattern. Market attention is now on the downside.
https://www.americanbulls.com/SignalPage.aspx?lang=en&Ticker=WDRP
Got it!
.0175!
PatScan could detect pipe bombs!
Thanks MSP!
What's this about Boing, NG, and LMT?
Are they partners too?
He appears very uncomfortable with his presentation. Mealy mouth, stuttering, and very low volume. Almost incoherent.
I do not think he believes in his company.
What is HIPA?
Is WDRP marketing to Canada?
"The Company is presently pursuing a number of acquisition transactions, which transactions are at various stages of development. Any such transaction will be fully disclosed if and at such time as it becomes material information regarding the Company."
Any ideas as to what is going on?
"In related news, on October 18th, Cisco
Systems has invited Patriot One, as one of
its innovation partners, to showcase to their
largest clients and partners our PATSCAN
family of threat detection solutions during their
annual Cisco Connect event at the Toronto
Congress Centre."
How much debt are they in?
Thanks!
State of the art security technology now in use at Las Vegas hotel privateofficer.org
https://privateofficerbreakingnews.blogspot.com/2018/10/state-of-art-security-technology-now-in.html?view=magazine&m=1
Has Wanderport indicated anything about the Oct 17 date in Canada, and launching product there?
Extending the Perimeter. The new software that integrates with existing video surveillance cameras.
This is big.
If you remember the Orlando nightclub shooting, for example, where the guy went to his car, got an assault rifle, walked through the parking lot, into the nightclub and then oppened fire on the helpless people inside.
Look at the sequence in these screenshots of this new technology, (another game changer) and how this will help counter these type of attacks in the future.
Advance warning allows for the threat to be met by security/law enforcement and dealt with on their terms! Mass casualties avoided. This is huge!
https://www.facebook.com/groups/889952311178139/permalink/1111840425655992/
Martin Cronin stated that, We already have over 10 Thousand qualified clients awaiting product delivery.